Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Altered brain glucose metabolism in transgenic-PFKL mice with elevated L-phosphofructokinase: in vivo NMR studies.

Peled-Kamar M, Degani H, Bendel P, Margalit R, Groner Y.

Brain Res. 1998 Nov 9;810(1-2):138-45.

PMID:
9813288
2.

Impaired glucose-induced insulin response in transgenic mice overexpressing the L-phosphofructokinase gene.

Knobler H, Weiss Y, Peled M, Groner Y.

Diabetes. 1997 Sep;46(9):1414-8.

PMID:
9287040
3.

Gene dosage and Down's syndrome: metabolic and enzymatic changes in PC12 cells overexpressing transfected human liver-type phosphofructokinase.

Elson A, Bernstein Y, Degani H, Levanon D, Ben-Hur H, Groner Y.

Somat Cell Mol Genet. 1992 Mar;18(2):143-61.

PMID:
1533471
4.

MRL/lpr mice have alterations in brain metabolism as shown with [1H-13C] NMR spectroscopy.

Alexander JJ, Zwingmann C, Quigg R.

Neurochem Int. 2005 Jul;47(1-2):143-51.

PMID:
15893408
5.
7.

Reduced cerebral blood flow but elevated cerebral glucose metabolic rate in erythropoietin overexpressing transgenic mice with excessive erythrocytosis.

Frietsch T, Maurer MH, Vogel J, Gassmann M, Kuschinsky W, Waschke KF.

J Cereb Blood Flow Metab. 2007 Mar;27(3):469-76. Epub 2006 Jun 28.

PMID:
16804549
8.

Tissue-dependent loss of phosphofructokinase-M in mice with interrupted activity of the distal promoter: impairment in insulin secretion.

Richard AM, Webb DL, Goodman JM, Schultz V, Flanagan JN, Getty-Kaushik L, Deeney JT, Yaney GC, Dunaway GA, Berggren PO, Tornheim K.

Am J Physiol Endocrinol Metab. 2007 Sep;293(3):E794-801. Epub 2007 Jun 26.

9.
10.
11.

Impaired brain glucose metabolism in patients with Down syndrome.

Labudova O, Cairns N, Kitzmüller E, Lubec G.

J Neural Transm Suppl. 1999;57:247-56.

PMID:
10666680
12.

Overexpression of hexokinase II increases insulinand exercise-stimulated muscle glucose uptake in vivo.

Halseth AE, Bracy DP, Wasserman DH.

Am J Physiol. 1999 Jan;276(1 Pt 1):E70-7.

13.

Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice.

Jenkins BG, Klivenyi P, Kustermann E, Andreassen OA, Ferrante RJ, Rosen BR, Beal MF.

J Neurochem. 2000 May;74(5):2108-19.

14.

Overexpression of c-myc in diabetic mice restores altered expression of the transcription factor genes that regulate liver metabolism.

Riu E, Ferre T, Mas A, Hidalgo A, Franckhauser S, Bosch F.

Biochem J. 2002 Dec 15;368(Pt 3):931-7.

15.
16.

Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase.

Xing Y, Musi N, Fujii N, Zou L, Luptak I, Hirshman MF, Goodyear LJ, Tian R.

J Biol Chem. 2003 Aug 1;278(31):28372-7. Epub 2003 May 23.

17.
18.

Cerebral metabolism of glucose and pyruvate in soman poisoning. A 13C nuclear magnetic resonance spectroscopic study.

Nguyen N, Gonzalez SV, Rise F, Hassel B.

Neurotoxicology. 2007 Jan;28(1):13-8. Epub 2006 Sep 30.

PMID:
17087995
19.
20.

Supplemental Content

Support Center